Compugen
CGEN
#8898
Rank
HK$1.10 B
Marketcap
HK$11.75
Share price
-6.21%
Change (1 day)
-5.03%
Change (1 year)

Earnings for Compugen (CGEN)

Earnings in 2025 (TTM): -HK$0.22 Billion

According to Compugen's latest financial reports the company's current earnings are HK$6.9 Million. In 2024 the company made an earning of -HK$75.59 Million, an increase over its 2023 earnings that were of -HK$76.17 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Compugen from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.22 Billion184.26%
2024 -HK$75.59 Million-0.77%
2023 -HK$76.17 Million-70.91%
2022 -HK$0.27 Billion-1.66%
2021 -HK$0.27 Billion15.17%
2020 -HK$0.24 Billion5.84%
2019 -HK$0.22 Billion24.16%
2018 -HK$0.18 Billion-39.03%
2017 -HK$0.29 Billion17.72%
2016 -HK$0.25 Billion59.22%
2015 -HK$0.16 Billion84.23%
2014 -HK$83.57 Million-20.97%
2013 -HK$0.11 Billion-5.86%
2012 -HK$0.12 Billion20.44%
2011 -HK$93.26 Million52.06%
2010 -HK$61.33 Million3.26%
2009 -HK$59.39 Million-37.67%
2008 -HK$95.28 Million-3.37%
2007 -HK$98.61 Million-8.64%
2006 -HK$0.11 Billion
2004 -HK$0.13 Billion9.57%
2003 -HK$0.12 Billion-5.5%
2002 -HK$0.12 Billion-20.9%
2001 -HK$0.15 Billion27.35%
2000 -HK$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-HK$6.16 Billion 2,768.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$73.87 Million-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.79 B-6,529.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Genetic Technologies
GENE
-HK$30.09 Million-85.98%๐Ÿ‡ฆ๐Ÿ‡บ Australia